These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7249253)
21. Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2,4-dione exhibit antitumor activity against L1210 leukemia. Nawrot-Modranka J; Ochocki J; Graczyk J Pharmazie; 2004 Sep; 59(9):731-2. PubMed ID: 15497762 [TBL] [Abstract][Full Text] [Related]
22. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase]. Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657 [TBL] [Abstract][Full Text] [Related]
23. Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells. Skórski T; Ratajczak MZ; Kawalec M; Kawiak J Folia Histochem Cytobiol; 1991; 29(3):121-4. PubMed ID: 1794437 [TBL] [Abstract][Full Text] [Related]
24. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine. Cohen MH J Pharmacol Exp Ther; 1975 Sep; 194(3):475-9. PubMed ID: 240017 [TBL] [Abstract][Full Text] [Related]
25. Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone. Gokhale PC; Pei J; Zhang C; Ahmad I; Rahman A; Kasid U Anticancer Res; 2001; 21(5):3313-21. PubMed ID: 11848489 [TBL] [Abstract][Full Text] [Related]
26. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. Elliott WL; Roberts BJ; Howard CT; Leopold WR Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790 [TBL] [Abstract][Full Text] [Related]
27. [Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22]. Yang YX; Zhu L; He X; Bao DY; Bao X Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):68-70. PubMed ID: 14981819 [TBL] [Abstract][Full Text] [Related]
28. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin. Zagozdzon R; Gołab J; Stokłosa T; Giermasz A; Nowicka D; Feleszko W; Lasek W; Jakóbisiak M Int J Cancer; 1998 Aug; 77(5):720-7. PubMed ID: 9688305 [TBL] [Abstract][Full Text] [Related]
29. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents. Schmid FA; Otter GM; Mehta BM Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147 [TBL] [Abstract][Full Text] [Related]
30. Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo. Golab J; Zagozdzon R; Kozar K; Kaminski R; Giermasz A; Stoklosa T; Lasek W; Jakobisiak M Oncol Rep; 2000; 7(1):177-81. PubMed ID: 10601614 [TBL] [Abstract][Full Text] [Related]
31. [Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice]. He H; Wang MY; Zhang TM Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):369-73. PubMed ID: 3195349 [No Abstract] [Full Text] [Related]
32. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice. Novotny L; Rauko P; Liska J; Elford HL; Szekeres T Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888 [TBL] [Abstract][Full Text] [Related]
33. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells. Miura T; Nogiwa E; Kurashige S; Maekawa T Cancer Res; 1980 Dec; 40(12):4813-6. PubMed ID: 7438114 [TBL] [Abstract][Full Text] [Related]
34. Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells. Watanabe T; Itoh S Cancer Immunol Immunother; 1997 Jun; 44(4):216-20. PubMed ID: 9222280 [TBL] [Abstract][Full Text] [Related]
35. [Development of leukemia L-1210 after treatment with the methionine synthetase inhibitor quinoline dibromide]. Kudriavtsev IA; Paramonova TD; Golenko OD; Miasishcheva NV Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):27-31. PubMed ID: 7122454 [No Abstract] [Full Text] [Related]
36. [Cancerostatic effect of some fluorenone azomethines tested against leukemia L 1210 (author's transl)]. Jungstand W; Gutsche W; Wohlrabe K; Schulze W Arch Geschwulstforsch; 1979; 49(1):15-7. PubMed ID: 444028 [TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of L-canavanine against L1210 murine leukemia. Green MH; Brooks TL; Mendelsohn J; Howell SB Cancer Res; 1980 Mar; 40(3):535-7. PubMed ID: 7471074 [TBL] [Abstract][Full Text] [Related]
38. Hyperbaric oxygen, whole-body X irradiation, and cyclophosphamide combination therapy in mouse leukemia L1210. Lottsfeldt FI; Schwartz S; Krivit W J Natl Cancer Inst; 1966 Jan; 36(1):37-43. PubMed ID: 5901526 [No Abstract] [Full Text] [Related]
39. [Effect of ethyl-O-[N-(p-carboxyphenyl) carbamoyl]-mycophenolate against L1210 leukemia]. Kato T; Ota K Gan To Kagaku Ryoho; 1985 Dec; 12(12):2327-30. PubMed ID: 4073927 [TBL] [Abstract][Full Text] [Related]
40. Effect of acetyl-L-carnitine on leukemia L1210 resistant to mitoxantrone. Niang M; Mĕlka M Acta Medica (Hradec Kralove); 2000; 43(4):125-8. PubMed ID: 11294129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]